227 related articles for article (PubMed ID: 21322159)
1. Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Wahba A; Vonk A; Bidstrup B
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):139-40. PubMed ID: 21322159
[No Abstract] [Full Text] [Related]
2. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery bypass grafting after aprotinin: are we doing better?
Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
5. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Yasim A; Aşik R; Atahan E
Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
[TBL] [Abstract][Full Text] [Related]
6. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin versus tranexamic acid: the controversy continues.
Levy JH
Transfusion; 2006 Mar; 46(3):319-20. PubMed ID: 16533270
[No Abstract] [Full Text] [Related]
8. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
9. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
10. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
[TBL] [Abstract][Full Text] [Related]
12. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
15. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
16. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of low dose tranexamic acid in primary cardiac surgery.
Lambert W; Brisebois FJ; Wharton TJ; Carrier RC; Boyle D; Rowe BH
Can J Anaesth; 1998 Jun; 45(6):571-4. PubMed ID: 9669014
[TBL] [Abstract][Full Text] [Related]
20. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
